BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21183462)

  • 1. Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR protein.
    Bar A; Marchand V; Khoury G; Dreumont N; Mougin A; Robas N; Stévenin J; Visvikis A; Branlant C
    Nucleic Acids Res; 2011 Apr; 39(8):3388-403. PubMed ID: 21183462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element.
    Fogel BL; McNally LM; McNally MT
    Nucleic Acids Res; 2002 Feb; 30(3):810-7. PubMed ID: 11809895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
    Maciolek NL; McNally MT
    J Virol; 2007 Oct; 81(20):11208-17. PubMed ID: 17670832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.
    McNally LM; McNally MT
    J Virol; 1996 Feb; 70(2):1163-72. PubMed ID: 8551577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juxtaposition of two distant, serine-arginine-rich protein-binding elements is required for optimal polyadenylation in Rous sarcoma virus.
    Hudson SW; McNally MT
    J Virol; 2011 Nov; 85(21):11351-60. PubMed ID: 21849435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that a threshold of serine/arginine-rich (SR) proteins recruits CFIm to promote rous sarcoma virus mRNA 3' end formation.
    Hudson SW; McNally LM; McNally MT
    Virology; 2016 Nov; 498():181-191. PubMed ID: 27596537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus.
    McNally LM; McNally MT
    Mol Cell Biol; 1998 Jun; 18(6):3103-11. PubMed ID: 9584151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
    Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
    J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular protein, hnRNP H, binds to the negative regulator of splicing element from Rous sarcoma virus.
    Fogel BL; McNally MT
    J Biol Chem; 2000 Oct; 275(41):32371-8. PubMed ID: 10934202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.
    McNally LM; McNally MT
    J Virol; 1999 Mar; 73(3):2385-93. PubMed ID: 9971822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing.
    McNally MT; Gontarek RR; Beemon K
    Virology; 1991 Nov; 185(1):99-108. PubMed ID: 1656608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR protein and snRNP requirements for assembly of the Rous sarcoma virus negative regulator of splicing complex in vitro.
    Cook CR; McNally MT
    Virology; 1998 Mar; 242(1):211-20. PubMed ID: 9501036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.
    Hibbert CS; Gontarek RR; Beemon KL
    RNA; 1999 Mar; 5(3):333-43. PubMed ID: 10094303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two regions promote U11 small nuclear ribonucleoprotein particle binding to a retroviral splicing inhibitor element (negative regulator of splicing).
    McNally LM; Yee L; McNally MT
    J Biol Chem; 2004 Sep; 279(37):38201-8. PubMed ID: 15252020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element.
    Swartz JE; Bor YC; Misawa Y; Rekosh D; Hammarskjold ML
    J Biol Chem; 2007 Jul; 282(27):19844-53. PubMed ID: 17513303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic sequences and 3' splice sites control Rous sarcoma virus RNA splicing.
    McNally MT; Beemon K
    J Virol; 1992 Jan; 66(1):6-11. PubMed ID: 1309264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA.
    LeBlanc JJ; Uddowla S; Abraham B; Clatterbuck S; Beemon KL
    Virology; 2007 Jul; 363(2):376-86. PubMed ID: 17328934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer.
    Asang C; Hauber I; Schaal H
    Nucleic Acids Res; 2008 Mar; 36(5):1450-63. PubMed ID: 18203748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.